Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4257318 | 0.98 | GABRA1 (0.44) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Hydrochloric Acid SCHEMBL827415 | 0.88 | GABRA1 (0.40) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL245773 | 0.82 | GABRA1 (0.57) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| SCHEMBL11228913 | 0.81 | BID (0.42) | GABRA1GABRB2KCNH2 | |
| SCHEMBL9407940 | 0.80 | HTT (0.45) | GABRA1GABRB2HTR1AKCNH2MAOA | |
| SCHEMBL11225510 | 0.80 | BID (0.45) | KCNH2 | |
| SCHEMBL11223954 | 0.80 | TP53 (0.41) | GABRA1GABRB2TAAR1HTR1ATP53 | |
| SCHEMBL31498538 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Methane SCHEMBL28776675 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 | |
| Methylamine SCHEMBL27545014 | 0.79 | GABRA1 (0.55) | GABRA1GABRB2TAAR1HTR1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1556 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036772-A | Synthesis method of beta-pinacol borate-alkyl ketone compound | 陇东学院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026090602-A1 | PIGMENTED RESIN AND CATALYST COMPOSITIONS | MATERIA, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4683900-A2 | ROMP AND THERMAL INSULATION COMPOSITIONS AND MATERIALS AND USE THEREOF | Materia, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497412-B2 | Compound as highly selective ROS1 inhibitor and use thereof | GUANGZHOU JOYO PHARMATECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| EP-3013886-B1 | THERMAL INSULATION | MATERIA INC (US) | 2025-03-26 | — | — | EP | claimed |
| EP-2961778-B1 | METAL CARBENE OLEFIN METATHESIS TWO CATALYST COMPOSITION | MATERIA INC (US) | 2025-02-26 | — | — | EP | claimed |
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CRYSTAL PHARMA, S.A.U. (ES) | 2025-01-28 | — | — | US | claimed |
| CN-111936117-B | Covalent treatment of keratin-containing materials | 生活实验公司 | 2025-01-07 | — | — | CN | claimed |
| CN-119158591-A | Magnetic nano noble metal catalyst, preparation method thereof, method for preparing hydrogenated nitrile rubber, hydrogenated nitrile rubber and application thereof | 中国石油化工股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| US-12162829-B2 | Gas phase process for acrylate production from ethylene and carbon dioxide | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-12-10 | — | — | US | claimed |
| US-4637987-A | Gas monitoring device and method | GOULD INC. (US) | 1987-01-20 | — | — | US | claimed |
| US-4544707-A | Manganese-tertiary phosphine-polymer complexes | GOULD INC. (US) | 1985-10-01 | — | — | US | claimed |
| US-4482640-A | NICKEL COMPOUND, PHOSPHINE, CARBOXYLIC ACID AS CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1984-11-13 | — | — | US | claimed |
| US-4459191-A | PHOTOINITIATORS, OLEFIN | PENNWALT CORPORATION (US) | 1984-07-10 | — | — | US | claimed |
| EP-0106911-A1 | Light-catalyzed process for preparing amines | PENNWALT CORPORATION (US) | 1984-05-02 | — | — | EP | claimed |
| US-4250063-A | COORDINATION CATALYST COMPRISING AN ORGANIC COMPLEX OF TUNGSTEN OR MOLYBDENUM, A TITANIUM TETRAHALIDE, AND AN N-HALO IMIDE, A SULFIDE, A SULFOXIDE, OR A PHOSPHINE; POLYALKENAMERS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-02-10 | — | — | US | claimed |
| US-4207258-A | HYDROGENATION | ANKERFARM S.P.A. (IT) | 1980-06-10 | — | — | US | claimed |
| US-4201728-A | RHODIUM METAL COMPLEX CATALYST | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | claimed |
| US-4169861-A | STAVILIZED RHODIUM METAL BIDENTATE LIGAND AND MONODENTATE LIGAND | CELANESE CORPORATION (US) | 1979-10-02 | — | — | US | claimed |
| US-3992322-A | Preparation of polymerization catalyst systems | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12497412-B2 | Compound as highly selective ROS1 inhibitor and use thereof | ROS1, NOX1, NOX4 | GABRA1 3316/4885GABRB2 3587/4885TAAR1 3106/4885 |
| US-12162829-B2 | Gas phase process for acrylate production from ethylene and carbon dioxide | MSMO1, ALOX15, ALOX12 | GABRA1 4036/4885GABRB2 4311/4885TAAR1 3912/4885 |
| US-12209107-B2 | Process for preparing high puritiy allopregnanolone and intermediates thereof | CYP21A2, CYP17A1, CYP11B1 | GABRA1 255/4885GABRB2 245/4885TAAR1 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.